Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury
Status:
Recruiting
Trial end date:
2022-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine the effectiveness and safety of mirabegron
compared to oxybutynin chloride immediate release (oxybutynin IR) for a condition called
neurogenic detrusor overactivity in individuals with chronic spinal cord injury (SCI).
Phase:
Phase 2
Details
Lead Sponsor:
Kessler Foundation
Collaborator:
National Institute on Disability, Independent Living, and Rehabilitation Research